Silverfin false 31/05/2023 08/02/2022 31/05/2023 W R Pike 08/02/2022 R A Skornia 08/02/2022 08 November 2023 The principal activity of the company during the financial period was providing services as locum pharmacists. 13901504 2023-05-31 13901504 bus:Director1 2023-05-31 13901504 bus:Director2 2023-05-31 13901504 core:CurrentFinancialInstruments 2023-05-31 13901504 core:Non-currentFinancialInstruments 2023-05-31 13901504 core:ShareCapital 2023-05-31 13901504 core:RetainedEarningsAccumulatedLosses 2023-05-31 13901504 core:Vehicles 2022-02-07 13901504 core:OfficeEquipment 2022-02-07 13901504 core:ComputerEquipment 2022-02-07 13901504 2022-02-07 13901504 core:Vehicles 2023-05-31 13901504 core:OfficeEquipment 2023-05-31 13901504 core:ComputerEquipment 2023-05-31 13901504 bus:OrdinaryShareClass1 2023-05-31 13901504 2022-02-08 2023-05-31 13901504 bus:FullAccounts 2022-02-08 2023-05-31 13901504 bus:SmallEntities 2022-02-08 2023-05-31 13901504 bus:AuditExemptWithAccountantsReport 2022-02-08 2023-05-31 13901504 bus:PrivateLimitedCompanyLtd 2022-02-08 2023-05-31 13901504 bus:Director1 2022-02-08 2023-05-31 13901504 bus:Director2 2022-02-08 2023-05-31 13901504 core:Vehicles core:TopRangeValue 2022-02-08 2023-05-31 13901504 core:OfficeEquipment core:TopRangeValue 2022-02-08 2023-05-31 13901504 core:ComputerEquipment core:TopRangeValue 2022-02-08 2023-05-31 13901504 core:Vehicles 2022-02-08 2023-05-31 13901504 core:OfficeEquipment 2022-02-08 2023-05-31 13901504 core:ComputerEquipment 2022-02-08 2023-05-31 13901504 core:Non-currentFinancialInstruments 2022-02-08 2023-05-31 13901504 bus:OrdinaryShareClass1 2022-02-08 2023-05-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 13901504 (England and Wales)

PHARMADERMA LIMITED

Unaudited Financial Statements
For the financial period from 08 February 2022 to 31 May 2023
Pages for filing with the registrar

PHARMADERMA LIMITED

Unaudited Financial Statements

For the financial period from 08 February 2022 to 31 May 2023

Contents

PHARMADERMA LIMITED

COMPANY INFORMATION

For the financial period from 08 February 2022 to 31 May 2023
PHARMADERMA LIMITED

COMPANY INFORMATION (continued)

For the financial period from 08 February 2022 to 31 May 2023
DIRECTORS W R Pike
R A Skornia
REGISTERED OFFICE Centenary House Peninsula Park
Rydon Lane
Exeter
EX2 7XE
United Kingdom
BUSINESS ADDRESS 23 Yon Street
Kingskerswell
Newton Abbot
Devon
TQ12 5EA
COMPANY NUMBER 13901504 (England and Wales)
CHARTERED ACCOUNTANTS Francis Clark LLP
Centenary House
Peninsula Park
Rydon Lane
Exeter
Devon EX2 7XE
PHARMADERMA LIMITED

BALANCE SHEET

As at 31 May 2023
PHARMADERMA LIMITED

BALANCE SHEET (continued)

As at 31 May 2023
Note 31.05.2023
£
Fixed assets
Tangible assets 3 27,086
27,086
Current assets
Debtors 4 15,732
Cash at bank and in hand 138,723
154,455
Prepayments and accrued income 11,025
Creditors: amounts falling due within one year 5 ( 93,489)
Net current assets 71,991
Total assets less current liabilities 99,077
Creditors: amounts falling due after more than one year 6 ( 43,047)
Net assets 56,030
Capital and reserves
Called-up share capital 7 100
Profit and loss account 55,930
Total shareholders' funds 56,030

For the financial period ending 31 May 2023 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of PharmaDerma Limited (registered number: 13901504) were approved and authorised for issue by the Board of Directors on 08 November 2023. They were signed on its behalf by:

W R Pike
Director
PHARMADERMA LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial period from 08 February 2022 to 31 May 2023
PHARMADERMA LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial period from 08 February 2022 to 31 May 2023
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial period, unless otherwise stated.

General information and basis of accounting

PharmaDerma Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Centenary House Peninsula Park, Rydon Lane, Exeter, EX2 7XE, United Kingdom. The principal place of business is 23 Yon Street, Kingskerswell, Newton Abbot, Devon, TQ12 5EA.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Turnover

Turnover is stated net of VAT and trade discounts and is recognised when the significant risks and rewards are considered to have been transferred to the buyer. Revenue from services is recognised as they are delivered.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a [straight-line, reducing balance] basis over its expected useful life, as follows:

Vehicles 5 years straight line
Office equipment 5 years straight line
Computer equipment 5 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Ordinary share capital

The ordinary share capital of the Company is presented as equity.

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

2. Employees

Period from
08.02.2022 to
31.05.2023
Number
Monthly average number of persons employed by the Company during the period, including directors 2

3. Tangible assets

Vehicles Office equipment Computer equipment Total
£ £ £ £
Cost
At 08 February 2022 0 0 0 0
Additions 12,295 754 16,264 29,313
At 31 May 2023 12,295 754 16,264 29,313
Accumulated depreciation
At 08 February 2022 0 0 0 0
Charge for the financial period 820 13 1,394 2,227
At 31 May 2023 820 13 1,394 2,227
Net book value
At 31 May 2023 11,475 741 14,870 27,086

4. Debtors

31.05.2023
£
Trade debtors 15,732

5. Creditors: amounts falling due within one year

31.05.2023
£
Taxation and social security 47,055
Obligations under finance leases and hire purchase contracts 4,838
Other creditors 41,596
93,489

6. Creditors: amounts falling due after more than one year

31.05.2023
£
Obligations under finance leases and hire purchase contracts 24,015
Other creditors 19,032
43,047

There are no amounts included above in respect of which any security has been given by the small entity.

7. Called-up share capital

31.05.2023
£
Allotted, called-up and fully-paid
100 Ordinary shares of £ 1.00 each 100

100 Ordinary shares with an aggregate nominal value of £100 were allotted upon incorporation and a consideration of £100 was received.